Health Care & Life Sciences » Pharmaceuticals | Walvax Biotechnology Co. Ltd.

Walvax Biotechnology Co. Ltd.

Walvax Biotechnology Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.69
Market Cap
CNY45 B
Shares Outstanding
1.38 B
Public Float
724.88 M

Profile

Address
19/F, Building 9A, Dingyi Tiancheng
Kunming Yunnan 650106
China
Employees -
Website http://www.walvax.com
Updated 07/08/2019
Walvax Biotechnology Co., Ltd. engages in the research and development, production, and sale of biopharmaceutical products. Its products include haemophilus influenzae type b conjugate vaccine in vials and pre-encapsulation type; lyophilized type A and C, and ACYW135 meningococcal polysaccharide conjugate vaccine. The company was founded on January 16, 2001 and is headquartered in Kunming, China.

Financials

View All

Yun Chun Li
Chairman
Zhen Huang
Director & Vice President